Sinomenine hydrochloride enhancement of the inhibitory effects of anti-transferrin receptor antibody-dependent on the COX-2 pathway in human hepatoma cells

Cancer Immunology, Immunotherapy

Volumn 62, Issue 3, 2013, Pages 447-454

  Hong, Yi ^a,b   Yang, Juan ^a   Shen, Xin ^a,b   Zhu, Huifen ^a   Sun, Xiaoxu ^a   Wen, Xue ^a   Bian, Jing ^a   Hu, Heyu ^a   Yuan, Lu ^a   Tao, Juan ^c   Lei, Ping ^a   Shen, Guanxin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Hepatoma; Monoclonal antibody; Sinomenine hydrochloride; Transferrin receptor

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; SINOMENINE; TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN; MONOCLONAL ANTIBODY; MORPHINAN DERIVATIVE; PTGS2 PROTEIN, HUMAN; VASCULOTROPIN A;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER IMMUNOLOGY; CANCER INHIBITION; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; CELL DIVISION; IMMUNOLOGY; LIVER TUMOR; METABOLISM;

ANTIBODIES, MONOCLONAL; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CYCLOOXYGENASE 2; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MORPHINANS; RECEPTORS, TRANSFERRIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MLCS; MLOWN;

EID: 84877133758     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1337-y     Document Type: Article

References (32)

1. Jone DT, Trowbridge IS, Harris AL (2006) Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate. Cancer Res 66:2749-2756
2. Daniels TR, Delgado T, Helguera G, Penichet ML (2006) The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin Immunol 121:159-176 (Pubitemid 44572972)
3. Habashy HO, Powe DG, Staka CM, Rakha EA, Ball G, Green AR et al (2010) Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Res Treat 119:283-293
4. Rodríguez JA, Luria-Pérez R, López-Valdés HE, Casero D, Daniels TR, Patel S et al (2011) Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells. Leuk Lymphoma 52:2169-2178
5. Huang RK, Steinmetz NF, Fu CY, Marianne Manchester M, Johnson JE (2011) Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells. Nanomedicine 6:55-68
6. Daniels TR, Ortiz-Sanchez E, Luria-Perez R, Quintero R, Helguera G, Bonavida B et al (2011) An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignancies. J Immunother 34:500-508
7. Qing Y, Shuo W, Zhihua W, Huifen Z, Ping L, Lijiang L et al (2006) The in vitro antitumor effect and in vivo tumor-specificity distribution of human-mouse chimeric antibody against transferrin receptor. Cancer Immunol Immunother 55:1111-1121 (Pubitemid 43800726)
8. Shen X, Zhu HF, He FR, Xing W, Li L, Liu J et al (2008) An anti-transferrin receptor antibody enhanced the growth inhibitory effects of chemotherapeutic drugs on human non-hematopoietic tumor cells. Int Immunopharmacol 8:1813-1820
9. Peng JL, Wu S, Zhao XP, Wang M, Li WH, Shen X et al (2007) Downregulation of transferrin receptor surface expression by intracellular antibody. Biochem Biophys Res Commun 354:864-871 (Pubitemid 46216213)
10. Tao J, Tu YT, Li JW, Feng AP, Huang CZ, Wu Y et al (2006) Endogenous production of nitric oxide contributes to proliferation effect of vascular endothelial growth factor-induced malignant melanoma cell. Clin Exp Dermatol 31:94-99
11. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669-676 (Pubitemid 36749215)
12. Liu Y, Tao J, Li Y, Yang J, Yu Y, Wang M et al (2009) Targeting hypoxia-inducible factor-1 alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth. Mol Ther 17:269-277
13. Huang WJ, Xia LM, Zhu F, Huang B, Zhou C, Zhu HF et al (2009) Transcriptional upregulation of HSP70-2 by HIF-1 in cancer cells in response to hypoxia. Int J Cancer 124:298-305
14. Yamasaki H (1976) Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum. Acta Med Okayama 30:1-20
15. Jin HZ, Wang XL, Wang HB, Wang YB, Lin LP, Ding J et al (2008) Morphinane alkaloid dimers from Sinomenium acutum. J Nat Prod 71:127-129 (Pubitemid 351236410)
16. Wang Q, Li XK (2011) Immunosuppressive and anti-inflammatory activities of sinomenine. Int Immunopharmacol 11:373-376
17. Kok TW, Yue PY, Mak NK, Fan TP, Liu L, Wong RN (2005) The anti-angiogenic effect of sinomenine. Angiogenesis 8:3-12 (Pubitemid 41223834)
18. Ju XD, Deng M, Ao YF, Yu CL, Wang JQ, Yu JK et al. (2010) Protective effect of sinomenine on cartilage degradation and chondrocytes apoptosis. Yakugaku Zasshi 130:1053-1060
19. Jiang T, Zhou L, Zhang W, Qu D, Xu X, Yang Y et al (2010) Effects of sinomenine on proliferation and apoptosis in human lung cancer cell line NCI-H460 in vitro. Mol Med Rep 3:51-56
20. Du H, Xiang J, Zhang Y, Tang Y (2007) A spectroscopic and molecular modeling study of sinomenine binding to transferring. Bioorg Med Chem Lett 17:1701-1704
21. Chen W, Shen Y, Zhao GS, Yao HP (2004) Inhibitory effect of sinomenine on expression of cyclooxygenase-2 in lipopolysaccharide-induced PC-12 cells. Zhongguo Zhong Yao Za Zhi 9:900-903
22. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L (2003) IL-1β-mediated up-regulation of HIF-1α via an NFκB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17:2115-2117
23. Yao L, Liu F, Hong L, Sun L, Liang S, Wu K et al (2011) The function and mechanism of COX-2 in angiogenesis of gastric cancer cells. J Exp Clin Cancer Res 30:13
24. Lei P, He Y, Ye Q, Zhu HF, Yuan XM, Liu J et al (2007) Antigen-binding characteristics of AbCD71 and its inhibitory effect on PHA-induced lymphoproliferation. Acta Pharmacol Sin 28:1659-1664 (Pubitemid 47493281)
25. Kawamoto M, Horibe H, Kohno M, Kawakami K (2011) novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells. BMC Cancer 18:359
26. Wang SJ, Sun B, Cheng ZX, Zhou HX, Gao Y, Kong R et al (2011) Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway. Cancer Chemother Pharmacol 68:1421-1430
27. Nagy VM, Buiga R, Brie I, Todor N, Tudoran O, Ordeanu C et al (2011) Expression of VEGF, VEGFR, EGFR, COX-2 and MVD in cervical carcinoma, in relation with the response to radio-chemotherapy. Rom J Morphol Embryol 52:53-59
28. Raspollini MR, Amunni G, Villanucci A, Boddi V, Taddei GL (2006) COX-2 and preoperative CA-125 level are strongly correlated with survival and clinical responsiveness to chemotherapy in ovarian cancer. Acta Obstet Gynecol Scand 85:493-498 (Pubitemid 43879201)
29. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-716 (Pubitemid 28257578)
30. Daniel TO, Liu H, Morrow JD, Crews BC, Marnett LJ (1999) Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 59:4574-4577 (Pubitemid 29428961)
31. Liang RY, Cao LY, Wang WJ, Liu XY, Wang PX (2007) Studies on anti-inflammatory mechanism of sinomenine. J Guang Zhou Univ Tradition Chin Med 24:141-143
32. Wang WJ, Wang PX (2002) Selective inhibitory effect of sinomenine on activity of cyclooxygenase 2. J Guang Zhou Univ Tradition Chin Med 19:46-51